Skip to main content

The Nose Knows: Why NeOnc’s Patent Portfolio Could Make NTHI More Than a One-Drug Biotech

Stunning Brain-Cancer Data Are Putting NeOnc’s Nose-to-Brain Delivery Platform, and Its Broader Potential, Front and Center DENVER, Aug. 13, 2026 (GLOBE NEWSWIRE) — NeOnc Technologies Holdings’ (NASDAQ: NTHI) August 12 headline was impossible to miss, but another interesting solution may be hiding in plain sight: while NeOnc produced encouraging data for one cancer drug, it also generated human clinical evidence around a non-invasive intranasal delivery strategy designed to reach the brain without relying on conventional systemic delivery across the blood-brain barrier. NeOnc’s own filings describe NEO100 as an intranasally administered formulation of purified perillyl alcohol and identify intranasal delivery as one of several approaches the company is investigating to overcome the blood-brain barrier. That distinction could ultimately...

Continue reading

DIAGNOS Receives Saudi FDA Medical Device License for CARA System, Bringing AI-Assisted Retinal Image Analysis to Saudi Arabia

BROSSARD, Quebec, Aug. 13, 2026 (GLOBE NEWSWIRE) — Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Corporation dedicated to the early detection of eye-related health using Artificial Intelligence (AI) techniques, is pleased to announce that today, August 13, 2026, it has received Medical Device Marketing Authorization for the CARA System (CARA) from the Saudi Food and Drug Authority (SFDA). The version of CARA licensed in Saudi Arabia includes detection algorithms for Diabetic Retinopathy (DR) and Age-related Macular Degeneration (AMD). CARA provides, in a short period of time and at an affordable unit cost, valuable insights to the healthcare provider, ultimately improving quality of life for the patient. According to the International Diabetes Federation (link), the adult population...

Continue reading

Norsk Hydro: Alunorte ramps up alumina production

Following the approval by Brazil’s oil, natural gas and biofuels regulator ANP to become self-importer of gas, Alunorte has reached a temporary agreement with its gas supplier CELBA regarding terminal access. The refinery has consequently begun increasing alumina production. The Alunorte refinery temporarily reduced alumina production as a contingency measure after CELBA notified Alunorte of disruptions to natural gas availability. Alunorte has reached an agreement with CELBA regarding temporary terminal access, while pursuing a long-term solution With the agreement in place, alumina production at Alunorte is being ramped up to full capacity. Lost production during the period of reduced alumina production is estimated to be 100,000 to 120,000 tonnes. Potential Q3 2026 financial impact for Bauxite & Alumina from the reduced production...

Continue reading

National Advertising Division Recommends Dreame Modify or Discontinue “2-Minute” Hair Drying Claims

In a challenge brought by Dyson Inc., BBB National Programs’ National Advertising Division recommended that Dreame Technology modify or discontinue advertising claims that its hair styling tools dry hair in two minutes to avoid conveying the unsupported message that the products can dry long hair in that time. New York, NY, Aug. 13, 2026 (GLOBE NEWSWIRE) — In a challenge brought by Dyson Inc., BBB National Programs’ National Advertising Division recommended that Dreame Technology modify or discontinue advertising claims that its hair styling tools dry hair in two minutes to avoid conveying the unsupported message that the products can dry long hair in that time. Fast-Track SWIFT is an expedited process designed for single-issue advertising cases before the National Advertising Division (NAD). Dyson and Dreame offer competing hair...

Continue reading

Share-based incentive programmes

Following the adoption today by the annual general meeting of the company’s revised Remuneration Policy, the Board of Directors has authorised a grant of share-based incentives. The grant comprises performance and restricted shares under the company’s existing long term incentive programme for 2026/27–2028/29 (the “LTIP”) and a one-off share option grant to the newly appointed Executive Management Board and a reserve for additional LTIP grants. The LTIP grant comprises a maximum of 2,388,770 shares and is governed by the LTIP terms outlined in company announcement of 9 July 2026. The share option programme comprises a maximum of 3,300,000 shares divided into three separate tranches with a base exercise price based on the share price at the time of grant. The exercise price is subject to compounding annual hurdle rates of 8%, 12% and 15%...

Continue reading

Cygnus Metals Limited: Scheme Booklet Registered by ASIC

TORONTO and PERTH, Western Australia, Aug. 13, 2026 (GLOBE NEWSWIRE) — Cygnus Metals Limited (ASX:CY5, TSXV:CYG, OTCQB:CYGGF) (Cygnus or the Company) refers to the proposed transaction under which Central Asia Metals PLC (AIM: CAML) (CAML) will acquire 100% of the shares in Cygnus pursuant to a scheme of arrangement under Part 5.1 of the Corporations Act 2001 (Cth) (Corporations Act) (Scheme). Scheme Booklet Cygnus confirms that the explanatory statement providing information about the Scheme (Scheme Booklet) has today been registered with the Australian Securities and Investments Commission (ASIC). A copy of the Scheme Booklet is filed on Cygnus’ SEDAR+ profile at www.sedarplus.ca and will also be made available on Cygnus’ website at https://www.cygnusmetals.com/investors and on Cygnus’ ASX market announcements platform at...

Continue reading

Cerebras Powers Ultrafast Mode for OpenAI’s GPT-5.6 Sol

Cerebras powers OpenAI’s most capable model at up to 14x the speed, giving frontier intelligence with no compromise on latency SUNNYVALE, Calif., Aug. 13, 2026 (GLOBE NEWSWIRE) — Cerebras (NASDAQ: CBRS) today announced that it is powering Ultrafast mode, a new service tier in the OpenAI API for GPT-5.6 Sol. Available initially in limited preview to OpenAI customers, Ultrafast runs GPT-5.6 Sol at up to 750 output tokens per second and up to 14× faster than Standard processing. GPT-5.6 Sol Ultrafast powered by Cerebras runs with the same intelligence as GPT-5.6 Sol Standard, enabling frontier intelligence at Cerebras’ blistering fast speed. Every major computing shift has been unlocked by a leap in speed, not just capability: the PC era needed the jump from kilohertz to gigahertz, and the internet needed the move from...

Continue reading

Sanofi: Information concerning the total number of voting rights and shares – July 2026

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’Autorité des Marchés Financiers (Regulation of the French stock market authority) Sanofia French société anonyme with a registered share capital of €2,415,546,786Registered office : 46, avenue de la Grande Armée – 75017 Paris – FranceRegistered at the Paris Commercial and Companies Registry under number 395 030 844Date   Total number of issued shares   Number of real voting rights(excluding treasury shares) Theoretical number of voting rights (including treasury shares)*July 31, 2026   1,207,773,393   1,336,308,574   1,343,475,636* Pursuant to Article 223-11 of the Règlement général de l’Autorité des Marchés...

Continue reading

Trupanion Partners with Home To Home® to Help More Pets Transition Directly from One Loving Home to Another

New partnership expands resources for new pet families, helping them start their journey with greater financial confidence and peace of mind SEATTLE, Aug. 13, 2026 (GLOBE NEWSWIRE) — Every pet deserves the opportunity to live a happy, healthy life in a loving home. But when life takes an unexpected turn, some families are faced with the heartbreaking decision to find a new home for a beloved companion. To help make those transitions easier, Trupanion, North America’s leading pet insurer, and Home To Home®, the direct pet rehoming platform, today announced a new partnership designed to support both pets and the families welcoming them into their homes. Beginning today, Home To Home adopters will receive access to Trupanion’s educational resources, including guidance on preparing for unexpected veterinary expenses and...

Continue reading

Mortgage Rates Average 6.67%

Primary Mortgage Market Survey®U.S. weekly average mortgage rates as of 08/13/2026MCLEAN, Va., Aug. 13, 2026 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) today released the results of its Primary Mortgage Market Survey® (PMMS®), showing the 30-year fixed-rate mortgage (FRM) averaged 6.67%. “Mortgage rates remained relatively stable this week at 6.67%,” said Sam Khater, Freddie Mac’s Chief Economist. “Housing affordability has improved from a year ago, and recent increases in purchase and refinance applications suggest that borrowers continue to respond to even modest changes in mortgage rates.” News FactsThe 30-year FRM averaged 6.67% as of August 13, 2026, down from last week when it averaged 6.69%. A year ago at this time, the 30-year FRM averaged 6.58%. The 15-year FRM averaged 5.96%,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.